Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Merck Sharp & Dohme (UK) Limited, 120 Moorgate, London, EC2M 6UR, UK
Esmeron 10 mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. pH: 3.8-4.2. |
Each ml Esmeron contains 10 mg rocuronium bromide.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Rocuronium |
Rocuronium is a fast onset, intermediate acting non-depolarising neuromuscular blocking agent, possessing all of the characteristic pharmacological actions of this class of medicinal products (curariform agents). It acts by competing for nicotinic cholinoceptors at the motor end-plate. |
| List of Excipients |
|---|
|
Esmeron contains the following excipients:
No preservative has been added. |
Esmeron 25 mg in 2.5 ml (10mg/ml):
Packaging of 10 vials each containing 25 mg rocuronium bromide.
Esmeron 50 mg in 5 ml (10mg/ml):
Packaging of 10 vials each containing 50 mg rocuronium bromide.
Esmeron 100 mg in 10 ml (10mg/ml):
Packaging of 10 vials each containing 100 mg rocuronium bromide.
Not all pack sizes may be marketed.
Type 1 Ph.Eur., clear, colourless, glass vial with a rubber closure and flip off cap. The rubber stopper of the vial does not contain latex.
In correspondence please quote lot number.
Merck Sharp & Dohme (UK) Limited, 120 Moorgate, London, EC2M 6UR, UK
PL 53095/0001
Date of first authorisation: 15th July 1996
Date of latest renewal: 7th May 2002
| Drug | Countries | |
|---|---|---|
| ESMERON | Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
